Sermorelin: Side effects and cancer risks
Food and Drug Administration (FDA) has now approved two oral GLP-1 drugs: an oral version of Novo Nordisks Wegovy at the end of 2025, and Eli Lillys daily, non-peptide pillorforglipron, a distinct competitor to oral semaglutide and different from Eli Lillys injectable tirzepatidecalled Foundayo in April, which is notable because it can be taken without restrictions on timing or food or water intake
Inside the formula Packed with an array of actives, theres also the gold standard hydrator hyaluronic acid, and the popular retinol alternative bakuchiol, known to help improve firmness and soften lines without the irritation typical of retinoids
The antioxidant system supports cancer progression by suppressing oxidative stress and increasing ROS-scavenging capacity
The direction still matters
Once DNA is methylated, it switches the genes off and therefore, S-adenosylmethionine can be considered to control gene expression